Gunnveig Grødeland, leader of the "Influenza and Adaptive Immunity research group at the Department of Immunology, the Division of Laboratory Medicine, has recently been interviewed for Uniforum, the digital newspaper for the University of Oslo. In the article - entitled "Gunnveig Grødeland is trying to avert the next pandemic" - she talks about vaccines, pandemics and how she got interested in immunology.
Published in major journals, first or last author from Oslo University Hospital.
A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply
N Engl J Med, 385 (16), e57
No Strong Evidence on Liver Transplant for Colorectal Cancer Liver Metastasis Over Portal Vein Embolization Associated With Liver Resection-Reply
JAMA Surg (in press)
Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead
Eur Urol (in press)